Putnam Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-182,189
Closed -$4.61M 1222
2023
Q2
$4.61M Buy
+182,189
New +$4.61M 0.01% 470